Characteristics of HIV-infected women and factors associated with HCV seropositivity in the Republic of Georgia

AIDS Research and Therapy

Volumn 8, Issue , 2011, Pages

  Chkhartishvili, Nikoloz ^a   McNutt, Louise Anne ^b   Smith, Perry F ^c   Tsertsvadze, Tengiz ^a,d  

^a Infectious Diseases AIDS and Clinical Immunology Research Center   (Georgia)

^b UNIVERSITY AT ALBANY   (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^d TBILISI STATE UNIVERSITY   (Georgia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DRUG USE; FEMALE; GEORGIA (REPUBLIC); HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PREVALENCE; PRIORITY JOURNAL; PROSTITUTION; SEXUALITY;

EID: 79960576118     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/1742-6405-8-25     Document Type: Article

References (41)

1. European Centre for Disease Prevention and Control/WHO Regional Office for Europe HIV/AIDS surveillance in Europe 2008. Book HIV/AIDS surveillance in Europe 2008 2009, City: European Centre for Disease Prevention and Control, (Editor ed.^eds.), European Centre for Disease Prevention and Control/WHO Regional Office for Europe.
2. Joint United Nations Programme on HIV/AIDS (UNAIDS) Global report: UNAIDS report on the global AIDS epidemic 2010. 2010, Geneva, Joint United Nations Programme on HIV/AIDS (UNAIDS).
3. Hamers FF, Downs AM. HIV in central and eastern Europe. Lancet 2003, 361:1035-1044. 10.1016/S0140-6736(03)12831-0, 12660072.
4. Rhodes T, Simic M. Transition and the HIV risk environment. BMJ 2005, 331:220-223. 10.1136/bmj.331.7510.220, 1179776, 16037463.
5. Abdala N, Carney JM, Durante AJ, Klimov N, Ostrovski D, Somlai AM, Kozlov A, Heimer R. Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia. Int J STD AIDS 2003, 14:697-703. 10.1258/095646203322387965, 14596774.
6. Booth RE, Mikulich-Gilbertson SK, Brewster JT, Salomonsen-Sautel S, Semerik O. Predictors of self-reported HIV infection among drug injectors in Ukraine. J Acquir Immune Defic Syndr 2004, 35:82-88. 10.1097/00126334-200401010-00012, 14707797.
7. Rhodes T, Platt L, Judd A, Mikhailova LA, Sarang A, Wallis N, Alpatova T, Hickman M, Parry JV. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia. Int J STD AIDS 2005, 16:749-754. 10.1258/095646205774763180, 16303071.
8. Butsashvili M, Tsertsvadze T, McNutt LA, Kamkamidze G, Gvetadze R, Badridze N. Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors. European journal of epidemiology 2001, 17:693-695. 10.1023/A:1015566132757, 12086085.
9. Shapatava E, Nelson KE, Tsertsvadze T, del Rio C. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia. Drug Alcohol Depend 2006, 82(Suppl 1):S35-38.
10. Stvilia K, Tsertsvadze T, Sharvadze L, Aladashvili M, del Rio C, Kuniholm MH, Nelson KE. Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T'bilisi, Republic of Georgia. J Urban Health 2006, 83:289-298. 10.1007/s11524-006-9032-y, 2527157, 16736377.
11. Curatio International Foundation, Public Union Bemoni Bio-behavioral surveillance surveys among injecting drug users in Georgia. Tbilisi 2009, Curatio International Foundation, Public Union Bemoni.
12. World Health Organization Regional Office for Europe HIV/AIDS Treatment and Care: Clinical protocols for the WHO European Region. 2007, Copenhagen, World Health Organization Regional Office for Europe.
13. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003, 157:940-943. 10.1093/aje/kwg074, 12746247.
14. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005, 162:199-200. 10.1093/aje/kwi188, 15987728.
15. Dore GJ, Kaldor JM. Detection of HCV RNA in semen. Lancet 2000, 356:1520.
16. Halfon P, Riflet H, Renou C, Quentin Y, Cacoub P. Molecular evidence of male-to-female sexual transmission of hepatitis C virus after vaginal and anal intercourse. J Clin Microbiol 2001, 39:1204-1206. 10.1128/JCM.39.3.1204-1206.2001, 87908, 11230462.
17. Vandelli C, Renzo F, Romano L, Tisminetzky S, De Palma M, Stroffolini T, Ventura E, Zanetti A. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol 2004, 99:855-859. 10.1111/j.1572-0241.2004.04150.x, 15128350.
18. Kao JH, Liu CJ, Chen PJ, Chen W, Lai MY, Chen DS. Low incidence of hepatitis C virus transmission between spouses: a prospective study. J Gastroenterol Hepatol 2000, 15:391-395. 10.1046/j.1440-1746.2000.02165.x, 10824883.
19. Marincovich B, Castilla J, del Romero J, Garcia S, Hernando V, Raposo M, Rodriguez C. Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples. Sex Transm Infect 2003, 79:160-162. 10.1136/sti.79.2.160, 1744643, 12690143.
20. Tahan V, Karaca C, Yildirim B, Bozbas A, Ozaras R, Demir K, Avsar E, Mert A, Besisik F, Kaymakoglu S, et al. Sexual transmission of HCV between spouses. Am J Gastroenterol 2005, 100:821-824. 10.1111/j.1572-0241.2005.40879.x, 15784025.
21. Feldman JG, Minkoff H, Landesman S, Dehovitz J. Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner city women. Sex Transm Dis 2000, 27:338-342. 10.1097/00007435-200007000-00007, 10907909.
22. Hershow RC, Kalish LA, Sha B, Till M, Cohen M. Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission. Sex Transm Dis 1998, 25:527-532. 10.1097/00007435-199811000-00006, 9858348.
23. Marx MA, Murugavel KG, Tarwater PM, SriKrishnan AK, Thomas DL, Solomon S, Celentano DD. Association of hepatitis C virus infection with sexual exposure in southern India. Clin Infect Dis 2003, 37:514-520. 10.1086/376639, 12905135.
24. Frederick T, Burian P, Terrault N, Cohen M, Augenbraun M, Young M, Seaberg E, Justman J, Levine AM, Mack WJ, Kovacs A. Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS). AIDS Patient Care STDS 2009, 23:915-923. 10.1089/apc.2009.0111, 2823487,2823487, 19877800.
25. Page-Shafer KA, Cahoon-Young B, Klausner JD, Morrow S, Molitor F, Ruiz J, McFarland W. Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection. Am J Public Health 2002, 92:670-676. 10.2105/AJPH.92.4.670, 11919070.
26. Thomas DL, Zenilman JM, Alter HJ, Shih JW, Galai N, Carella AV, Quinn TC. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships. J Infect Dis 1995, 171:768-775. 10.1093/infdis/171.4.768, 7535827.
27. Thomas DL. Hepatitis C and human immunodeficiency virus infection. Hepatology 2002, 36:S201-209.
28. Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. BMC Infect Dis 2006, 6:93. 10.1186/1471-2334-6-93, 1524784, 16762050.
29. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996, 86:655-661. 10.2105/AJPH.86.5.655, 1380472, 8629715.
30. Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, Yu XF. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 2004, 33:182-188. 10.1093/ije/dyh019, 15075167.
31. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR. Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and Risks. Journal of Infectious Diseases 2002, 186:1558-1564. 10.1086/345554, 12447730.
32. Judd A, Hickman M, Jones S, McDonald T, Parry JV, Stimson GV, Hall AJ. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ 2005, 330:24-25. 10.1136/bmj.38286.841227.7C, 539846, 15533854.
33. Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol 1997, 35:3274-3277. 230161, 9399533.
34. Orlando R, Lirussi F. Hepatitis C virus infection: sexual or non-sexual transmission between spouses? A case report and review of the literature. Infection 2007, 35:465-468. 10.1007/s15010-007-6188-7, 17906840.
35. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010, 375:1014-1028. 10.1016/S0140-6736(10)60232-2, 20189638.
36. McDavid K, McKenna MT. HIV/AIDS risk factor ascertainment: A critical challenge. AIDS Patient Care STDS 2006, 20:285-292. 10.1089/apc.2006.20.285, 16623627.
37. Murphy JT, Mueller GE, Whitman S. Redefining the Growth of the Heterosexual HIV/AIDS Epidemic in Chicago. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:122-126. 10.1097/00042560-199710010-00008, 9358107.
38. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007, 18:352-358. 10.1016/j.drugpo.2007.04.004, 17854722.
39. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372:1733-1745. 10.1016/S0140-6736(08)61311-2, 18817968.
40. Butsashvili M, Preble E, Kamkamidze G, Robinson J, Chubinishvili O, Sukhiashvili R. Uptake of an HIV voluntary counseling and testing program for pregnant women in Georgia. AIDS Care 2008, 20:1125-1127. 10.1080/09540120701842837, 18825518.
41. Tsertsvadze T, Kakabadze T, Shermadini K, Abutidze A, Karchava M, Chkhartishvili N, Badridze N, Bokhua Z, Asatiani T. Prevention of mother-to-child transmission of HIV: the Georgian experience. Cent Eur J Public Health 2008, 16:128-133.